openPR Logo
Press release

Cataract Market Poised to Grow at 7.6% CAGR, Reaching USD 17.9 Billion by 2034

09-22-2025 02:03 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Cataract Market

Cataract Market

Introduction
Cataracts, characterized by the clouding of the eye's natural lens, remain the leading cause of blindness worldwide. The condition is strongly linked to aging, though it can also result from trauma, prolonged steroid use, diabetes, and genetic predispositions. Cataracts significantly impair vision, daily functioning, and overall quality of life, making them one of the most pressing ophthalmic health concerns.

Over the last two decades, cataract management has undergone a transformation, with surgery emerging as the gold-standard treatment. Modern cataract surgery-particularly phacoemulsification and femtosecond laser-assisted techniques-combined with premium intraocular lenses (IOLs), has achieved remarkable success in restoring vision. With rising life expectancy, technological innovations, and expanding access to ophthalmic care, the Cataract Market is set for robust growth over the forecast period.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72246

Market Overview
• Market Size (2024): Estimated at USD 8.6 billion
• Forecast (2034): Expected to reach USD 17.9 billion
• CAGR (2024-2034): Projected at 7.6%

Key Growth Drivers
• Global rise in the geriatric population, the primary risk group for cataracts.
• Technological advancements in surgical devices and premium IOLs.
• Expanding availability of affordable cataract procedures in emerging markets.
• Increased government and NGO initiatives for blindness prevention.

Key Challenges
• Limited access to surgery in rural and low-income regions.
• High cost of premium IOLs and laser-assisted surgeries.
• Post-surgical complications in certain high-risk patients.
• Shortage of trained ophthalmic surgeons in developing nations.

Leading Players
Alcon (Novartis), Johnson & Johnson Vision, Bausch + Lomb, Carl Zeiss Meditec, Hoya Corporation, STAAR Surgical, NIDEK, Rayner, and other ophthalmic device innovators.

Segmentation Analysis
By Surgery Type
• Phacoemulsification
• Extracapsular Cataract Extraction (ECCE)
• Femtosecond Laser-Assisted Cataract Surgery (FLACS)
• Intracapsular Cataract Extraction (rare, legacy approach)

By Intraocular Lens (IOL) Type
• Monofocal IOLs
• Multifocal IOLs
• Toric IOLs
• Accommodating IOLs
• Advanced/Custom IOLs (Blue-light filtering, Extended Depth of Focus)

By End User
• Hospitals
• Ophthalmology Clinics
• Ambulatory Surgical Centers
• Research & Academic Institutes

By Distribution Channel
• Direct Sales (to hospitals/clinics)
• Retail Optical and Surgical Equipment Suppliers
• Online Distribution (emerging)

Segmentation Summary
Phacoemulsification dominates as the global standard of care, while femtosecond laser-assisted cataract surgery is the fastest-growing technique due to precision benefits. Among IOLs, monofocal lenses remain the largest segment, but premium IOLs (multifocal, toric, EDOF) are gaining traction among affluent patients seeking spectacle independence.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72246/cataract-market

Regional Analysis
North America
• 2024 Market Size: USD 3.2 billion
• 2034 Forecast: USD 6.4 billion
• CAGR: 7.2%
The U.S. dominates due to high surgical adoption, availability of premium IOLs, and advanced ophthalmology infrastructure.

Europe
• 2024 Market Size: USD 2.5 billion
• 2034 Forecast: USD 5.0 billion
• CAGR: 7.3%
Germany, France, and the U.K. lead, supported by national blindness-prevention programs and reimbursement for cataract surgeries.

Asia-Pacific
• 2024 Market Size: USD 2.1 billion
• 2034 Forecast: USD 5.6 billion
• CAGR: 9.2%
China and India represent the largest cataract patient pools, with rapid expansion of low-cost cataract surgery programs supported by governments and NGOs. Japan and South Korea lead in premium IOL adoption.

Middle East & Africa
• 2024 Market Size: USD 0.4 billion
• 2034 Forecast: USD 0.8 billion
• CAGR: 7.0%
Saudi Arabia and South Africa are improving surgical infrastructure, though rural access remains limited.

Latin America
• 2024 Market Size: USD 0.4 billion
• 2034 Forecast: USD 0.9 billion
• CAGR: 7.5%
Brazil and Mexico dominate regional markets, supported by government blindness-elimination programs.

Regional Summary
North America and Europe dominate in premium IOL adoption, while Asia-Pacific leads in patient volume and growth, driven by mass-screening and subsidized surgical programs.

Market Dynamics
Key Growth Drivers
• Expanding elderly population and rising cataract prevalence.
• Advancements in minimally invasive surgical techniques.
• Growing popularity of premium intraocular lenses.
• Strong public-private partnerships in blindness prevention.

Key Challenges
• Cost barriers for advanced surgical options.
• Shortage of trained ophthalmic surgeons in low-income regions.
• Unequal access between urban and rural healthcare facilities.
• Post-surgical care and complication risks in certain populations.

Latest Trends
• Increasing adoption of femtosecond laser-assisted cataract surgery (FLACS).
• Development of next-gen IOLs offering better visual outcomes.
• Growth of mobile surgical units in underserved regions.
• Integration of AI and robotics in cataract diagnostics and surgery planning.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72246

Competitor Analysis
Key Companies
• Alcon (Novartis) - Market leader in surgical equipment and premium IOLs.
• Johnson & Johnson Vision - Strong global footprint in cataract surgery solutions.
• Bausch + Lomb - Wide portfolio in ophthalmic surgical devices.
• Carl Zeiss Meditec - Innovator in surgical visualization and diagnostics.
• Hoya Corporation - Leading IOL provider with global reach.
• STAAR Surgical - Specialized in implantable lenses.
• NIDEK - Strong in surgical equipment and refractive technology.
• Rayner - Focused on premium intraocular lens innovation.

Competitive Dynamics
The cataract market is highly consolidated, with major players dominating surgical devices and IOLs. Premium IOL innovation, affordability strategies, and geographic expansion into Asia-Pacific and Latin America are key competitive priorities.

Conclusion
The Cataract Market is projected to grow from USD 8.6 billion in 2024 to USD 17.9 billion by 2034, at a CAGR of 7.6%.
Opportunities Ahead
• Expansion of premium IOLs targeting spectacle independence.
• Growth in Asia-Pacific cataract surgery programs.
• Integration of AI and robotics for surgical precision.
• Wider adoption of low-cost cataract interventions in underserved regions.

Key Takeaways
• Cataracts remain the leading cause of preventable blindness globally.
• Surgery is the gold standard, with premium IOLs driving innovation.
• North America and Europe lead in advanced adoption, while Asia-Pacific is the fastest-growing region.
• Accessibility and affordability will remain central to shaping the future market landscape.

This report is also available in the following languages : Japanese (白内障市場), Korean (백내장 시장), Chinese (白内障市场), French (Marché de la cataracte), German (Kataraktmarkt), and Italian (Mercato della cataratta), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72246

Our More Reports:

Diabetic Foot Market
https://exactitudeconsultancy.com/reports/72010/diabetic-foot-market

Cushing's Syndrome Market
https://exactitudeconsultancy.com/reports/72008/cushing-s-syndrome-market

Alphamannosidosis Market
https://exactitudeconsultancy.com/reports/72006/alphamannosidosis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cataract Market Poised to Grow at 7.6% CAGR, Reaching USD 17.9 Billion by 2034 here

News-ID: 4192312 • Views:

More Releases from Exactitude Consultancy

Childhood Atropine for Myopia Progression Market Poised to Grow at 9.9% CAGR, Reaching USD 2.8 Billion by 2034
Childhood Atropine for Myopia Progression Market Poised to Grow at 9.9% CAGR, Re …
Introduction Myopia, or nearsightedness, has reached epidemic proportions worldwide, with prevalence surging particularly in children. Without effective interventions, childhood myopia often progresses to high myopia, significantly raising the risk of retinal detachment, glaucoma, cataracts, and myopic macular degeneration later in life. One of the most promising treatments for slowing myopia progression in children is low-dose atropine therapy. Clinical studies have demonstrated that low concentrations of atropine (0.01% to 0.05%) are effective in
Central Serous Chorioretinopathy Market Forecast to Grow at 7.8% CAGR, Reaching USD 1.45 Billion by 2034
Central Serous Chorioretinopathy Market Forecast to Grow at 7.8% CAGR, Reaching …
Introduction Central Serous Chorioretinopathy (CSC) is a retinal disorder characterized by the accumulation of fluid under the retina, leading to distorted or blurred vision. While acute cases often resolve spontaneously, chronic CSC can result in permanent visual impairment due to retinal pigment epithelium damage. The condition primarily affects men between the ages of 30 and 50 and is associated with risk factors such as corticosteroid use, stress, hypertension, and Type A
Allergic Rhino-Conjunctivitis Market to Expand at 7.3% CAGR, Reaching USD 21.9 Billion by 2034
Allergic Rhino-Conjunctivitis Market to Expand at 7.3% CAGR, Reaching USD 21.9 B …
Introduction Allergic rhino-conjunctivitis (ARC) is one of the most common allergic disorders globally, characterized by nasal congestion, sneezing, itching, watery eyes, and conjunctival inflammation. Triggered primarily by pollen, dust mites, pet dander, and environmental pollutants, ARC significantly impacts quality of life and productivity. It is often seasonal but can also persist year-round in patients with perennial allergen exposure. As urbanization, air pollution, and climate change exacerbate allergic diseases, the patient pool for
Adult Myopia Market Forecast to Grow at 7.6% CAGR, Reaching USD 40.2 Billion by 2034
Adult Myopia Market Forecast to Grow at 7.6% CAGR, Reaching USD 40.2 Billion by …
Introduction Myopia, or nearsightedness, is one of the most common refractive errors worldwide, affecting both children and adults. In adults, untreated or progressive myopia can lead to significant vision impairment, increased risk of retinal detachment, glaucoma, and myopic macular degeneration. Driven by lifestyle changes such as increased screen exposure, reduced outdoor activity, and urbanization, the prevalence of adult myopia is growing at an unprecedented rate. The Adult Myopia Market is positioned for

All 5 Releases


More Releases for IOL

PMMA IOL Market Size 2024 to 2031.
Market Overview and Report Coverage PMMA IOL, or polymethyl methacrylate intraocular lens, is a type of artificial lens implanted in the eye during cataract surgery. It is known for its durability, optical clarity, and biocompatibility. The PMMA IOL Market is experiencing steady growth and is expected to continue expanding in the coming years. Factors driving this growth include the rising prevalence of cataract cases due to aging population, increasing awareness
Spherical IOL Market- Projections & Estimations, Forecast by 2020-2029
The report includes vital information on the current size and projected growth of the entire market for spherical iol and its relevant sectors. It also includes market characteristics, top suppliers, consumer preference patterns, and geographic market potential. Dhirtek Business Research and Consulting created this study using both primary and secondary sources. Primary sources included core and associated industry specialists, as well as those associated with service providers, deployment engineers, maintenance
Global Aspheric IOL Market - Opportunities & Forecasts, 2020-2029
The research report from Dhirtek Business Research and Consulting is a thorough examination of the global aspheric iol market. Subject matter experts and a team of highly trained researchers have worked tirelessly to compile an original research report on the global aspheric iol market. Analysts have researched the various items on the market and provided unbiased opinions on the variables that are expected to drive and constrain the market. To
Intraocular Lens (IOL) Market Size - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Intraocular Lens (IOL) Market is projected to grow from USD 4.2 billion in 2022 to USD 5.8 billion by 2027 at a CAGR value of 4.4% from 2022 to 2027. The market will be driven during the forecast period owing to, rising prevalence of eye diseases and diabetes in the overall population around the world, technological
Intraocular Lens (IOL) Market 2022 | Detailed Report
The research reports on “Intraocular Lens (IOL) Market” report gives detailed overview of factors that affect global business scope. Intraocular Lens (IOL) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @
Market Analysis: Intraocular Lens (IOL) Market on the Rise
The global intraocular lens (IOL) market size is projected to reach USD 5,318.8 million by 2026, thereby exhibiting a CAGR of 6.8% during the forecast period. However, the market was worth USD 3,159.3 million in 2018. This information is published in a recent report by Fortune Business Insights(TM), titled, "Intraocular Lens (IOL) Market Size, Share & Industry Analysis, By Type [Monofocal Intraocular Lens and Premium Intraocular Lens (Multifocal Intraocular Lens,